Literature DB >> 11381132

Maintenance of TCR clonality in T cells expressing genes for two TCR heterodimers.

D B Sant'Angelo1, P Cresswell, C A Janeway, L K Denzin.   

Abstract

T cell receptor (TCR) allelic exclusion is believed to be primarily mediated by suppression of further recombination at the TCR locus after the expression of a functional TCR protein. Genetic allelic exclusion has been shown to be leaky for the beta chain and, more commonly, for the alpha chain. Here, we demonstrate an additional mechanism by which T cells can maintain monoclonality. T cells from double TCR transgenic mice express only one or the other of the two available TCRs at the cell surface. This "functional allelic exclusion" is apparently due to control of the TCR assembly process because these T cells express RNA and protein for all four transgenic TCR proteins. Lack of cell surface expression of the second TCR may be controlled by a failure to assemble the TCR heterodimer.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11381132      PMCID: PMC34437          DOI: 10.1073/pnas.121179998

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  42 in total

1.  Cross-antagonism of a T cell clone expressing two distinct T cell receptors.

Authors:  B N Dittel; I Stefanova; R N Germain; C A Janeway
Journal:  Immunity       Date:  1999-09       Impact factor: 31.745

2.  The T-cell repertoire is heavily influenced by tolerance to polymorphic self-antigens.

Authors:  A M Pullen; P Marrack; J W Kappler
Journal:  Nature       Date:  1988-10-27       Impact factor: 49.962

3.  Characterization of a murine monoclonal antibody specific for an allotypic determinant on T cell antigen receptor.

Authors:  U D Staerz; H G Rammensee; J D Benedetto; M J Bevan
Journal:  J Immunol       Date:  1985-06       Impact factor: 5.422

4.  Tolerance in T-cell-receptor transgenic mice involves deletion of nonmature CD4+8+ thymocytes.

Authors:  P Kisielow; H Blüthmann; U D Staerz; M Steinmetz; H von Boehmer
Journal:  Nature       Date:  1988-06-23       Impact factor: 49.962

5.  T-cell-specific deletion of T-cell receptor transgenes allows functional rearrangement of endogenous alpha- and beta-genes.

Authors:  H Blüthmann; P Kisielow; Y Uematsu; M Malissen; P Krimpenfort; A Berns; H von Boehmer; M Steinmetz
Journal:  Nature       Date:  1988-07-14       Impact factor: 49.962

6.  Expression of two T cell receptor alpha chains on the surface of normal murine T cells.

Authors:  W R Heath; F R Carbone; P Bertolino; J Kelly; S Cose; J F Miller
Journal:  Eur J Immunol       Date:  1995-06       Impact factor: 5.532

7.  Alpha beta and gamma delta T cells can share a late common precursor.

Authors:  E C Dudley; M Girardi; M J Owen; A C Hayday
Journal:  Curr Biol       Date:  1995-06-01       Impact factor: 10.834

8.  Allelic exclusion of mouse T cell receptor alpha chains occurs at the time of thymocyte TCR up-regulation.

Authors:  S M Alam; I N Crispe; N R Gascoigne
Journal:  Immunity       Date:  1995-10       Impact factor: 31.745

9.  Normal T lymphocytes can express two different T cell receptor beta chains: implications for the mechanism of allelic exclusion.

Authors:  E Padovan; C Giachino; M Cella; S Valitutti; O Acuto; A Lanzavecchia
Journal:  J Exp Med       Date:  1995-04-01       Impact factor: 14.307

10.  Dual T cell receptor alpha chain T cells in autoimmunity.

Authors:  J I Elliott; D M Altmann
Journal:  J Exp Med       Date:  1995-10-01       Impact factor: 14.307

View more
  9 in total

1.  Segmented Filamentous Bacteria Provoke Lung Autoimmunity by Inducing Gut-Lung Axis Th17 Cells Expressing Dual TCRs.

Authors:  C Pierce Bradley; Fei Teng; Krysta M Felix; Teruyuki Sano; Debdut Naskar; Katharine E Block; Haochu Huang; Kenneth S Knox; Dan R Littman; Hsin-Jung Joyce Wu
Journal:  Cell Host Microbe       Date:  2017-11-08       Impact factor: 21.023

2.  TLR agonists downregulate H2-O in CD8alpha- dendritic cells.

Authors:  Gavin W Porter; Woelsung Yi; Lisa K Denzin
Journal:  J Immunol       Date:  2011-09-14       Impact factor: 5.422

3.  Enhanced antitumor activity of murine-human hybrid T-cell receptor (TCR) in human lymphocytes is associated with improved pairing and TCR/CD3 stability.

Authors:  Cyrille J Cohen; Yangbing Zhao; Zhili Zheng; Steven A Rosenberg; Richard A Morgan
Journal:  Cancer Res       Date:  2006-09-01       Impact factor: 12.701

4.  Monogenic TCRβ Assembly and Expression Are Paramount for Uniform Antigen Receptor Specificity of Individual αβ T Lymphocytes.

Authors:  Erica J Culberson; Craig H Bassing
Journal:  J Immunol       Date:  2022-06-13       Impact factor: 5.426

5.  Longitudinal analysis of the T-cell receptor (TCR)-VA and -VB repertoire in CD8+ T cells from individuals immunized with recombinant hepatitis B surface antigen.

Authors:  H Höhn; C Neukirch; K Freitag; A Necker; W Hitzler; B Seliger; M J Maeurer
Journal:  Clin Exp Immunol       Date:  2002-08       Impact factor: 4.330

Review 6.  Harnessing innate and adaptive immunity for adoptive cell therapy of renal cell carcinoma.

Authors:  Christiane Geiger; Elfriede Nössner; Bernhard Frankenberger; Christine S Falk; Heike Pohla; Dolores J Schendel
Journal:  J Mol Med (Berl)       Date:  2009-03-07       Impact factor: 4.599

7.  Enhanced antitumor activity of T cells engineered to express T-cell receptors with a second disulfide bond.

Authors:  Cyrille J Cohen; Yong F Li; Mona El-Gamil; Paul F Robbins; Steven A Rosenberg; Richard A Morgan
Journal:  Cancer Res       Date:  2007-04-15       Impact factor: 12.701

8.  Germinal center B cells regulate their capability to present antigen by modulation of HLA-DO.

Authors:  Kim S Glazier; Sandra B Hake; Helen M Tobin; Amy Chadburn; Elaine J Schattner; Lisa K Denzin
Journal:  J Exp Med       Date:  2002-04-15       Impact factor: 14.307

9.  Allelic exclusion of TCR α-chains upon severe restriction of Vα repertoire.

Authors:  Vasily Rybakin; Luise Westernberg; Guo Fu; Hee-Ok Kim; Jeanette Ampudia; Karsten Sauer; Nicholas R J Gascoigne
Journal:  PLoS One       Date:  2014-12-12       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.